Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) Polymorphisms in Familial and Sporadic Breast Cancer Predisposition and Survival: An Indian Report
- 4 December 2008
- journal article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 15 (3) , 389-397
Abstract
The etiology of a significant proportion of familial breast cancers is still poorly understood, with known high penetrance gene mutations accounting for only a small proportion of the cases. The increased risk of breast cancer for the majority of women with a family history likely reflects shared minor low penetrant genetic factors. In the present case-control study undertaken to examine the influence of DNA damage repair gene polymorphisms in familial and sporadic breast cancer susceptibility, 219 Sporadic and 140 familial breast cancer patients and 367 controls were genotyped using PCRRFLP. Odds Ratios (ORs) and 95% Confidence Intervals (95%CIs) were calculated by unconditional logistic regression adjusted to age. Variant genotypes XRCC1 Arg/Gln or Gln/Gln and XPD Lys/Gln or Gln/Gln increased both familial and sporadic breast cancer susceptibility. However, when the intra group risk was compared, the risk due to the XPD polymorphic genotypes Lys/Gln or Gln/Gln was significantly lower among familial breast cancer patients compared to sporadic breast cancer patients [OR = 0.61; 95%CI = 0.39–0.94; p value = 0.024) whereas the risk implied by XRCC1 variant genotype was not significantly different between the familial and nonfamilial groups of breast cancer patients [OR = 0.97; 95%CI = 0.63–1.49; p value = 0.882]. Both these variant genotypes were not associated with the disease characteristics or survival of either familial or sporadic breast cancer patients. This study represents an addition to previous published work on GSTs from the same study population and substantiates the hypothesis that the impact of the low penetrance gene polymorphisms differ by family history of the disease.Keywords
This publication has 48 references indexed in Scilit:
- An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancerBreast Cancer Research and Treatment, 2006
- Breast Cancer Susceptibility and the DNA Damage ResponseCancer Control, 2005
- Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancerBreast Cancer Research and Treatment, 2005
- Polymorphism in the DNA Repair Gene XPD, Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, and Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2004
- ERCC2 Genotypes and a Corresponding Haplotype Are Linked with Breast Cancer Risk in a German PopulationCancer Epidemiology, Biomarkers & Prevention, 2004
- Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patientsExperimental & Molecular Medicine, 2004
- How nucleotide excision repair protects against cancerNature Reviews Cancer, 2001
- Mutations in XPD helicase prevent its interaction and regulation by p44, another subunit of TFIIH, resulting in Xeroderma pigmentosum (XP) and trichothiodystrophy (TTD) phenotypes.1998
- DNA repair proficiency: a potential marker for identification of high risk members in breast cancer familiesCancer Letters, 1998
- DNA Repair Proficiency: Potential Susceptibility Factor for Breast CancerJNCI: Journal of the National Cancer Institute, 1996